Skip to content

Role of Ayurvedic medicines in eczema

ROLE OF VISHAGHNA MAHAKASHAYA AND PATOLKATUROHINYAD IKASHAYA IN VICHARCHIKA W.S.R. XENOBIOTICS: A RANDOMIZED COMPRARATIVE STUDY

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024134
Enrollment
30
Registered
2020-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L208- Other atopic dermatitis

Interventions

Intervention1: Patolakaturohinyadi kashaya: Patolakaturohinyadi kashaya will be given in 15 patients of vicharchikaa. dose - 20 ml twice a day after meal route of administration - orally duration - 30

Sponsors

National institute of Ayurveda jaipur jorawar singh gate aamber road jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient with the classical sign and symptoms of vicharchikaa, 2. Patient 18 years to 60 years of age will be included. 3. Patients belonging to either gender will be included.

Exclusion criteria

Exclusion criteria: 1.The patient suffering from systemic disorders (e.g. DM, HIV etc) will be excluded 2. The pregnant women and lactating mother will be excluded. 3. Patient less than 18years and above 60 years of age will be excluded.

Design outcomes

Primary

MeasureTime frame
Changes in the clinical manifestation of vicharchika.Timepoint: 45 Days

Secondary

MeasureTime frame
â?¢Changes in parameters of vicharchikaa.Timepoint: 45 days

Countries

India

Contacts

Public ContactDr Pooja

National institute of ayurveda, jaipur

anita31sharma@yahoo.com9414078653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026